A novel clinical radiomics nomogram to predict disease activity in Crohn's disease
Yu Liu1, Tingting Li2, Zhenlong Wang3
1Department of Radiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Objective:
To develop and validate a novel CT enterography (CTE)-based radiomics nomogram for predicting disease activity in Crohn's disease (CD).
Methods:
The CTE images and clinical data of 133 CD patients were retrospectively collected. The CTE-based radiomics features were extracted and screened by t-test and least absolute shrinkage and selection operator regression algorithm. Significant clinical variables were identified by multifactor logistic regression analysis. Then a combined model of clinical and radiomics features was established by multifactorial logistic regression, and a nomogram was plotted.
Results:
11 and 16 best radiomics features were screened based on CTE venous phase and arterial phase images, respectively. The area under ROC curve (AUC) of the venous radiomics model was higher than that of the arterial radiomics model on both the training and test sets (0.948 vs 0.927, 0.915 vs 0.878). Venous CT value, erythrocyte sedimentation rate and C-reactive protein were clinically relevant independent predictors of CD activity, and the AUC of the clinical model constructed from the 3 predictors was 0.873 and 0.822 on the training set and test set, respectively. The combined model had AUCs of 0.968 and 0.944 on the training and test sets, respectively. And the accuracy, sensitivity, and specificity were 0.900, 0.913, and 0.882 on the test set, respectively, which were higher than the other models.
Conclusions:
We develop a novel clinical radiomics nomogram to predict CD activity, which can assist clinicians in individualized treatment.
Advances In Knowledge:
This study is a novel attempt to establish a combined clinical-imaging graph model to predict the CD activity.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Receiver Operating Characteristic Plot


